These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. They are not penny stocks with absolutely no track record or...
Here are five biotech stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, these are not penny...
Tuesday's top analyst upgrades and downgrades included CrowdStrike, Gap, Marathon Petroleum, Mastercard, MGM Resorts, Palo Alto Networks, Snowflake and Visa.